# Prebiotic Treatment in People With Schizophrenia - Pilot Study

> **NCT03617783** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 26 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Prebiotin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03617783
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-18
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-04-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03617783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03617783, "Prebiotic Treatment in People With Schizophrenia - Pilot Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03617783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*